Product Code: PH198
REPORT KEY FINDINGS/RECOMMENDATIONS
- Position dedicated health economics groups under market access structure.
- Complete HEOR efforts throughout the product lifecycle.
- Use outsourcing to fill knowledge gaps and meet market needs.
- Focus HEOR spending on targeted HEOR studies and payer relationships.
- Consider product type when determining HEOR study complexity.
WHY CLIENTS NEED THIS REPORT/TOP BENEFITS
Due to their high costs, medical devices are early and easy targets for cost-cutting measures. To succeed against these increasing pressures, device companies arm themselves with health economics data to satisfy payer requirements and maintain optimal price levels. The benchmarks and best practices in this report guide medical device firms to take several steps toward meeting payer needs throughout the product lifecycle:
- Better understand the competitive landscape and marketplace when making HEOR study decisions.
- Outsource HEOR activities to fill knowledge gaps and provide data to meet payer demands.
- Structure medical device HEOR groups to meet payer requirements for information.
- Allocate budgets and resources effectively for HEOR studies.
- Understand the annual costs of supporting HEOR for medical device products.
- Choose the right types of HEOR studies to meet payer demands.
- Real-company examples and case studies showing device HEOR group structures.
- Benchmarks and best practices for staffing HEOR groups and outsourcing activities.
- Compensation data for HEOR positions across different levels of experience.
- Annual HEOR spending data for Class II and Class III medical devices.
- Strategic recommendations and insights on selecting HEOR studies that will help drive reimbursement.
- Data are split, where relevant:
- By Group Type:
- And by Region:
CHAPTER BENEFITS AND METRICS BREAKDOWN
Chapter - 1
The increasing levels of resources dedicated to health economics and outcomes research highlight the growing importance of these functions. This chapter explores device organizations' HEOR structures and staffing resources. Research in this chapter shows prevalent HEOR team structures at the global and country levels. Data also show how teams leverage staff to complete various cross-functional activities throughout a product's lifecycle. Finally, the chapter examines key trends impacting health economics teams' operations.
- Transition medical device companies from clinical-oriented to reimbursement-focused teams.
- Establish dedicated (global and country-level) health economics groups with vice president leadership to ensure that teams have the necessary support.
- Grow global and country-level health economics teams to navigate increasingly complex reimbursement landscapes.
- Involve HEOR groups throughout innovative product development.
- Plan for the continued growth of HEOR and other health economics functions as payers and hospitals increasingly adopt high standards.
- Leverage payers' emphasis on comparative effectiveness research to gain largest impact on HEOR teams.
17 charts detailing structure, outsourcing and functions associated with HEOR groups at medical device companies. Where relevant, data are broken down by geography (global/country-level groups).
- Structure of medical device HEOR groups
- Function overseeing medical device HEOR groups
- Number of FTEs dedicated to HEOR functions, by position (global/country-level)
- Real-company diagrams of medical device HEOR structures
- HEOR groups involved in activities (global/country-level)
- Time spent on specific activities (global/country-level)
- HEOR groups involved in developing innovative new products (by development phase, by company type)
- Percentage of companies using patient-reported outcomes (PROs)
- Percentage of companies outsourcing patient-reported outcomes (PROs) activities
- Reliability of patient-reported outcomes (PROs)
Chapter - 2
This chapter discusses the major activities and cost drivers for HEOR groups at medical device companies. It covers the differences in HEOR spending between Class II and Class III medical devices, as well as how companies should look at the marketplace to understand the role that HEOR groups can play. Companies should make sure that compensation rates for HEOR employees remain competitive. The chapter also examines outsourcing practices and how companies balance in-house activities and third-party vendors.
- Tailor outsourcing activities to match payer needs in terms of clinical trial data or market research.
- Understand competition and alternative treatments when determining appropriate HEOR spend.
- Plan budgets to account for differing levels of support between different types of medical devices.
7 charts detailing spending and compensation benchmarks for HEOR companies. Where relevant, data are split by category (overhead, salaries, HEOR studies), by activity (managing vendors, government/private payer information, valuating products, organizing data, clinical trial design) and by level (HEOR department head, management, HOL).
- Annual HEOR spending for Class II and Class III medical devices, by company
- Percentage of medical device HEOR spending (by category, activity)
- Annual compensation for HEOR-related positions at medical device companies (base salary, average bonus)
- Percentage of HEOR budget outsourced annually (by company)
Chapter - 3
This chapter shows the costs and durations of different types of HEOR studies medical device companies conduct to best achieve reimbursement. It also covers the number of each type of study that surveyed companies conduct each year, from 2012 through 2014. This data analysis examines the many different reasons - ranging from cost to marketplace to payers - a company chooses one HEOR study over another.
- Consider where product falls in treatment pathway when developing HEOR study goals.
- Set reachable goals for study duration and plan HEOR strategy accordingly.
- Understand market needs when deciding which types of studies are appropriate.
13 charts detailing duration, cost and number of studies conducted by HEOR groups. Where relevant, data are split by study type and by geography (global/country).
- Duration of studies conducted by medical device HEOR teams, by company: all studies
- Cost of studies conducted by medical device HEOR teams, by study type: all companies
Number of studies conducted by global HEOR teams, by company:
- Budget impact model (stand-alone)
- Pricing threshold model
- Cost effectiveness model
- All models
Cost of studies conducted by device HEOR teams, by company:
- Cost effectiveness model
- Pricing threshold model
Table of Contents
Chapter 1: Building a Robust Health Economics Foundation through Structure and Staffing
Chapter 2: Understanding Medical Device HEOR Spending and Outsourcing
Chapter 3: Selecting the Most Appropriate HEOR Study to Maintain Ideal Cost and Duration